Audited Financials Results for the quarter and financial year ended March 31, 2026
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tata Chemicals reported a consolidated net loss of ₹1,715 crore for FY2026 versus a profit of ₹387 crore in FY2025, driven primarily by a ₹1,837 crore goodwill impairment on its US operations due to adverse market conditions and geopolitical headwinds. Revenue from operations declined marginally to ₹14,584 crore from ₹14,887 crore. The company recorded total exceptional items (net) of ₹1,956 crore, including the US impairment, additional Lostock (UK) closure costs of ₹65 crore, and ₹54 crore labour code impact. Operating profit before exceptional items fell to ₹330 crore from ₹492 crore. The Board recommended a dividend of ₹11 per share. Statutory auditors BSR & Co. LLP issued an unmodified opinion.
The large goodwill impairment and operating loss are likely to significantly weigh on the stock in the near term, though the ₹11 dividend and clean audit opinion provide some cushion. The ₹1,837 crore US impairment signals structural challenges in the North American business.